(Q40678339)

22 September 2017

title

Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions (English)

1 reference

22 September 2017

1 reference

T A Nicholl

1

1 reference

22 September 2017

C R Nimmo

2

1 reference

22 September 2017

J D Shepherd

3

1 reference

22 September 2017

P Phillips

4

1 reference

22 September 2017

P J Jewesson

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

Annals of Pharmacotherapy

22 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 September 2017

volume

29

1 reference

22 September 2017

issue

11

1 reference

22 September 2017

page(s)

1081-1087

1 reference

Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Clinical use of amphotericin B and derivatives: lore, mystique, and fact

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

CKryptococcosis treated by rapid infusion of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Rapid intravenous infusion of amphotericin B: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Antifungal prophylaxis in immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Reduction of renal function by newer nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Risk factors of ventricular fibrillation during rapid amphotericin B infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

Risk of ventricular dysrhythmias during 1-hour infusions of amphotericin B in patients with preserved renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901101

10.1177/106002809502901101

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference